Buy Curos Caps Review

A 2024 meta-analysis in Infection Control and Hospital Epidemiology confirmed that antiseptic barrier caps significantly reduce infection rates, particularly in ICUs, and found them highly cost-effective with median savings of $21,890 per CLABSI prevented.

led to a and an estimated annual savings of nearly $300,000 for the studied hospital. buy curos caps

If you are looking for evidence to support buying or implementing 3M Curos Disinfecting Caps Go to product viewer dialog for this item. A 2024 meta-analysis in Infection Control and Hospital

A study published in ClinicoEconomics and Outcomes Research A study published in ClinicoEconomics and Outcomes Research

This official Summary of Peer-Reviewed Studies compiles data from multiple medical centers showing infection rate declines (e.g., from 1.36 to 0.47 per 1,000 catheter days) and high staff preference (100% in some audits) for caps over manual scrubbing. Benefits Highlighted in Literature